Presentation Information
[RL-02]Combination therapy of 211At-labeled RGD peptide and immune checkpoint inhibitors
Kazuma Ogawa1, Hiroaki Echigo1, Masayuki Munekane1, Takeshi Fuchigami2, Kohshin Washiyama3, Kazuhiro Takahashi3, Hiroshi Wakabayashi4, Seigo Kinuya4 (1.Kyoto University, Kyoto, Japan, 2.Fukushima Medical University, Fukushima, Japan, 3.Fukushima Medical University, Fukushima, Japan, 4.Kanazawa University, Kanazawa, Japan)
